Search for: "LUPIN, LTD."
Results 81 - 100
of 131
Sorted by Relevance
|
Sort by Date
14 Jul 2010, 6:47 pm
Cadila Healthcare Ltd. et al. [read post]
10 May 2010, 10:37 am
In contrast, the Federal Circuit’s 1990 decision in Glaxo Operations UK Ltd. v. [read post]
21 Jan 2010, 1:00 am
Lupin, Ltd. et al. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
22 Apr 2014, 11:56 pm
Lupin Ltd., 2011 WL 1897322 (D. [read post]
15 Jun 2011, 4:56 am
Lupin Ltd. et al. [read post]
16 Aug 2016, 5:15 pm
Apotex tried IPR to invalidate a Wyeth patent.In March 2013, Apotex filed a petition to institute interpartes review of the ’828 patent [of Wyeth]. [read post]
25 Nov 2009, 12:00 pm
US: Federal Circuit to hear oral argument in Ajinomoto v ITC 10 December (ITC Law Blog) US: Athena Diagnostics files suits against Ambry Genetics over alleged infringement of patents covering diagnostic technologies (Patent Docs) Products Dovonex (Calcipotriol) – UK: EWCA (Civ): Follow the instruction or lose the case - Sandoz's attempts at having finding of lack of anticipation overturned fails, appeal dismissed: Leo v Sandoz (IPKat) Famvir (Famciclovir) – US: New Jersey… [read post]
10 Aug 2010, 8:44 pm
General Coverage of anti-counterfeit policy debate varies widely across global media (IP Watch) WHO declares flu pandemic over; experts behind response to be revealed (IP Watch) Australia: TGA to implement alert system for new ARTG registrations (IP Whiteboard) EU: Final petition of the Advocate-General / Jodosulfuron- SPC for plant protection products (EPLAW) India: Parliamentary Committee on Health tables report on issues relating to availability of generic medicines (Spicy IP) Peru:… [read post]
22 Feb 2012, 5:49 pm
Lupin, Ltd. et al. [read post]
13 May 2010, 4:58 pm
Ltd. et al. v. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc, Cephalon… [read post]
22 Apr 2014, 11:29 pm
Lupin, Ltd., 676 F.3d 1316,1319 (Fed. [read post]
10 Nov 2010, 6:22 am
Lupin Pharms., Inc., 603 F.3d 1377 (Fed. [read post]
4 Aug 2015, 11:27 am
” Alcon Research Ltd. v. [read post]
27 Apr 2011, 4:55 am
(IP Watch) China: Pfizer starts R&D in China after IPR in China challenges (IP Dragon) UK: IPO inviting comment on C-630/10 University of Queensland, CSL Ltd v Comptroller-General of Patents, Designs and Trade Marks and C-130/11 Neurim v Comptroller General of Patents (The SPC Blog) (The SPC Blog) US: New generics quickly grab 80% of sales volume (GenericsWeb) Products Actos (Pioglitazone) – US: Takeda agrees to dismiss one Actos infringement suit against Apotex (Patent Docs)… [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
22 Jul 2008, 7:51 pm
Lupin, Ltd., 499 F.3d 1293, 1301 (Fed. [read post]
24 Mar 2010, 4:45 am
Lupin Ltd. et al. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
